Developer of antibody-drug conjugates designed for the treatment of multiple diseases. The company's conjugates use protein conjugation technology that allows the attachment of any two proteins together quickly and more selectively than any competing method by attaching the natural amino acids Tyrosine and Cysteine, enabling researchers to create novel therapeutics in autoimmune disorders, oncology, and vaccine development.